Although JQ1 was originally described to preferentially inhibit Myc transcriptional networks in multiple myeloma,11 new studies identify additional pathway effects for BET inhibition in alternate model systems.2,43 Furthermore, BET inhibitors not only inhibit transcription of BET activated genes, but they also induce transcription of BET repressed genes. The gene discussed is MYC; the disease is plasma cell myeloma.